Fda Staff Backs Injection To Reduce Double Chin

Reuters, Bangor Daily News
Fri, 03/06/2015 - 5:03am

An injection for “double chin” reduction developed by Kythera Biopharmaceuticals Inc. cleared the first hurdle toward approval as U.S. Food and Drug Administration staff concluded the drug’s benefits outweighed its risks. Kythera’s stock jumped as much as 25 percent as investors bet on what could be the first approved drug …

1
2
3

Sections: u.s.

Topics: Maine Penobscot County Bangor

RELATED ARTICLES

1
2
3